Huiming Zhang, Ph.D.

Program Director

Imaging Technology Development Branch

Dr. Huiming Zhang is a Program Director in the Image Technology Development Branch of the Cancer Imaging Program, Division of Cancer Treatment and Diagnosis at the National Cancer Institute (NCI). Dr. Zhang earned her Ph.D. in solid-state NMR Biophysics from the University of Louisville and completed postdoctoral training at the University of Virginia. She broadened her expertise in NMR/MRI/Molecular imaging as an instructor at the Biochemistry Department of the University of Chicago, senior NMR spectroscopist at the Evanston Northwestern Healthcare Research Institute, research assistant professor at the Radiology Department of Northwestern University, and a scientific imaging editor of the NIH Molecular Imaging Contrast Agent Database (MICAD). Her research interest included enzyme dynamics by solid-state NMR, protein structures by high-resolution NMR, preclinical functional MRI, MRI contrast agents and mechanisms, NMR/MRI instrumentation and hardware, image data processing, and molecular/metabolic imaging. In 2009, she joined the NCI Cancer Imaging Program as a program director. Her recent activities included the organization of international workshops on hyperpolarized 13C MRI, diffusion-weighted MRI, metabolic imaging, quantitative MRI, a meeting session on quantitative PET/CT, and management of the NCI Co-Clinical Imaging Research Resources (CIRP) program.